A Long-Term Study of Acotiamide in Patients with Functional Dyspepsia: Results from an Open-Label Phase III Trial in Japan on Efficacy, Safety and Pattern of Administration

Digestion ◽

10.1159/000332404 ◽

2011 ◽

Vol 84 (4) ◽

pp. 261-268 ◽

Author(s):

K. Matsueda ◽

M. Hongo ◽

S. Ushijima ◽

H. Akiho

Keyword(s):

Functional Dyspepsia ◽

Phase Iii ◽

Phase Iii Trial ◽

Long Term Study ◽

Open Label Phase

Download Full-text

A Long-Term Study of Acotiamide in Patients With Functional Dyspepsia : Results From an Open-Labeled Phase III Trial in Japan on Safety and Efficacy

Gastroenterology ◽

10.1016/s0016-5085(11)63336-2 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-805

Author(s):

Kei Matsueda ◽

Michio Hongo ◽

Satoshi Ushijima ◽

Hiraku Akiho ◽

Hiroki Kato

Keyword(s):

Functional Dyspepsia ◽

Phase Iii ◽

Phase Iii Trial ◽

Safety And Efficacy ◽

Long Term Study

Download Full-text

22 24-months on treatment: Open-label phase I/II long-term study of enzyme replacement therapy (ERT) with Gene-Activated® human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2007.08.027 ◽

2007 ◽

Vol 92 (4) ◽

pp. 16

Author(s):

Ari Zimran ◽

G. Altarescu ◽

C. Fratazzi ◽

R. Mensah ◽

D. Elstein

Keyword(s):

Enzyme Replacement Therapy ◽

Phase I ◽

Gaucher Disease ◽

Type I ◽

Enzyme Replacement ◽

Long Term Study ◽

Open Label Phase

Download Full-text

118. 36 months on treatment: Open-label phase I/II long-term study of enzyme replacement therapy (ERT) with “gene-activated” human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2007.10.130 ◽

2008 ◽

Vol 93 (2) ◽

pp. 45

Author(s):

Ari Zimran ◽

Kiran Bhirangi ◽

Robert Mensah ◽

Gheona Altarescu ◽

Deborah Elstein

Keyword(s):

Enzyme Replacement Therapy ◽

Phase I ◽

Gaucher Disease ◽

Type I ◽

Enzyme Replacement ◽

Long Term Study ◽

Open Label Phase

Download Full-text

Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs

Modern Rheumatology ◽

10.3109/14397595.2014.899179 ◽

2014 ◽

Vol 24 (5) ◽

pp. 744-753 ◽

Author(s):

Tsutomu Takeuchi ◽

Tsukasa Matsubara ◽

Yukitomo Urata ◽

Eiichi Suematsu ◽

Shuji Ohta ◽

...

Keyword(s):

Japanese Patients ◽

Phase Iii ◽

Inadequate Response ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Long Term Study ◽

Disease Modifying

Download Full-text

A randomised, comparative, open label phase III trial on efficacy and safety of long-term treatment with ICL670 (5 to 40 mg/kg/day) in comparison with deferoxamine (DFO) (20 to 60 mg/kg/day) in β-thalassaemia patients with transfusional haemosiderosis

http://isrctn.org/> ◽

10.1186/isrctn93355192 ◽

2012 ◽

Author(s):

Elliot Vichinsky

Keyword(s):

Term Treatment ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Trial ◽

Long Term Treatment ◽

Open Label Phase

Download Full-text

Safety and tolerability of brexpiprazole in adults with schizophrenia: results of an open-label, long-term study

10.26226/morressier.5971be85d462b80290b524fb ◽

2017 ◽

Author(s):

Catherine Weiss

Keyword(s):

Long Term Study

Download Full-text

Effect of brexpiprazole on long-term remission in adults with schizophrenia: results of an open-label, long-term study

10.26226/morressier.5971be85d462b80290b52514 ◽

2017 ◽

Author(s):

Ross Baker

Keyword(s):

Long Term Study

Download Full-text

K-924 Phase III 52 Weeks Long Term Study

Case Medical Research ◽

10.31525/ct1-nct04289662 ◽

2020 ◽

Author(s):

Keyword(s):

Phase Iii ◽

Long Term Study

Download Full-text

Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.014 ◽

2021 ◽

Author(s):

Hidemi Nakagawa ◽

Osamu Nemoto ◽

Atsuyuki Igarashi ◽

Hidehisa Saeki ◽

Kenji Kabashima ◽

...

Keyword(s):

Atopic Dermatitis ◽

Pediatric Patients ◽

Controlled Study ◽

Phase 3 ◽

Double Blind ◽

Long Term Study

Download Full-text

An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.12607 ◽

2017 ◽

Vol 72 (2) ◽

pp. 84-94 ◽

Author(s):

Hironobu Ichikawa ◽

Michio Hiratani ◽

Akihiro Yasuhara ◽

Noa Tsujii ◽

Takashi Oshimo ◽

...

Keyword(s):

Children And Adolescents ◽

Autistic Disorder ◽

Safety And Efficacy ◽

Long Term Study ◽

Open Label Extension

Download Full-text